The DNA‐binding drugs mithramycin and chromomycin are powerful inducers of erythroid differentiation of human K562 cells
Open Access
- 1 February 1999
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 104 (2) , 258-265
- https://doi.org/10.1046/j.1365-2141.1999.01173.x
Abstract
The British Journal of Haematology publishes original research papers in clinical, laboratory and experimental haematology. The Journal also features annotations, reviews, short reports, images in haematology and Letters to the Editor.Keywords
This publication has 36 references indexed in Scilit:
- Erythroid Progenitor Proliferation is Stimulated by Phenoxyacetic and Phenylalkyl AcidsBlood Cells, Molecules, and Diseases, 1996
- Alteration of the expression of human estrogen receptor gene by distamycinThe Journal of Steroid Biochemistry and Molecular Biology, 1995
- Binding of Epstein-Barr virus nuclear antigen 1 to DNA: inhibition by distamycin and two novel distamycin analoguesEuropean Journal of Pharmacology: Molecular Pharmacology, 1994
- Treatment with Azacitidine of Patients with End-Stage β-ThalassemiaNew England Journal of Medicine, 1993
- Enhancement by retinoid of hemin-induced differentiation of human leukemia K562 cell lineFEBS Letters, 1993
- Mithramycin blocks protein binding and function of the SV40 early promoter.Journal of Clinical Investigation, 1989
- Efficient cell proliferation and predominant accumulation of ɛ-globin mRNA in human leukemic K562 cells which produce mostly Hb Gower 1Cellular and Molecular Life Sciences, 1985
- Human leukemia K-562 cells: induction of erythroid differentiation by 5-azacytidineCell Differentiation, 1984
- Predominant expression of σ and ε globin genes in human leukemia K-562(S6) variant cell lineCellular and Molecular Life Sciences, 1983
- K562 human leukaemic cells synthesise embryonic haemoglobin in response to haeminNature, 1979